FDA Approved: NOREPINEPHRINE — Supplemental Application (Long Grove Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved a supplemental application for norepinephrine bitartrate (NOREPINEPHRINE) from Long Grove Pharmaceuticals, LLC under NDA 214628.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypotension
• Septic Shock
• Shock

Drugs mentioned

• NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE)

Snippet

SUPPL AP for NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE)